Home This week in gene and cell therapy - 8 March 2019 Gene and cell therapy headlines 4 - 8 March Biogen enters ophthalmology gene therapy field with Nightstar takeover Roche becomes a major gene therapy player with the acquisition of Spark Therapeutics Targetgin Nr4a transcription factors a possible strategies for combatting CAR-T cell exhaustion in solid tumour treatment Second patient HIV free after stem cell transplant: renewed interest in gene therapies targeting CCR5? Gilead and MaxCyte expand CAR-T partnership Orchard presents encouraging follow up data of trial of stem cell gene therapy for ADA-SCID Autolus partners with software company Veneti to make production and delivery of CAR-T cell therapies more efficient BioPharm partners with Trinity College Dublin to develop cell-based cancer treatments